Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcturus Therapeutics Ltd.

11.22
-0.7800-6.50%
Post-market: 11.300.0800+0.71%19:59 EDT
Volume:3.86M
Turnover:43.22M
Market Cap:304.67M
PE:-5.05
High:12.07
Open:12.00
Low:10.72
Close:12.00
52wk High:24.17
52wk Low:8.04
Shares:27.15M
Float Shares:25.02M
Volume Ratio:0.82
T/O Rate:15.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2225
EPS(LYR):-2.9978
ROE:-24.57%
ROA:-13.00%
PB:1.32
PE(LYR):-3.74

Loading ...

Jun 30, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 24, 2022

Major Issues Report

8-K - Current report
May 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2022

Major Issues Report

8-K - Current report
Apr 20, 2022

Major Issues Report

8-K - Current report
Mar 01, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2022

Major Issues Report

8-K - Current report
Feb 17, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Major Issues Report

8-K - Current report
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2022

Major Issues Report

8-K - Current report
Dec 13, 2021

Major Issues Report

8-K - Current report
Nov 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 04, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 26, 2021

Major Issues Report

Arcturus Therapeutics Holdings Inc.
Aug 26, 2021

Major Issues Report

8-K - Current report